Clinical Trials
151 trialsSandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Grupo Espanol de Tumores Neuroendocrinos
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
M.D. Anderson Cancer Center
TNE-bien-DIF
Assistance Publique - Hôpitaux de Paris
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
ArTisaN
Imperial College London
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
MGMT-NET
Hospices Civils de Lyon
TALENT
Grupo Espanol de Tumores Neuroendocrinos
GAPET-NET
University Hospital, Brest
CABATEN
Grupo Espanol de Tumores Neuroendocrinos
GEP-NENs
Tongji Hospital
SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors
Jewish General Hospital
SEQTOR
Grupo Espanol de Tumores Neuroendocrinos
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Memorial Sloan Kettering Cancer Center
FETONET
Imperial College London
GENEBIOLuNET
University Hospital, Toulouse
NUTRIGETNE
Grupo Espanol de Tumores Neuroendocrinos
18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
Memorial Sloan Kettering Cancer Center
A Transfer Learning Radiomics Model for Predicting Response to Initial Transarterial Embolization in Patients with Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases
First Affiliated Hospital, Sun Yat-Sen University
TEGRELE
Central Hospital, Nancy, France
Dual-Tracer Theranostic PET
University of Utah
Validation of 99mTc- EDDA - HYNIC -TOC Kits for Diagnosis of Neuroendocrine Tumors
Latin American Cooperative Oncology Group
Cabozantinib and Nivolumab for Carcinoid Tumors
Dana-Farber Cancer Institute
NEMESIs
University Hospital, Basel, Switzerland
AIM-NETs
Asan Medical Center
ECHO-NET
Istituto Clinico Humanitas
LuX
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
Grupo Espanol de Tumores Neuroendocrinos
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
University of Michigan Rogel Cancer Center
DUNE
Grupo Espanol de Tumores Neuroendocrinos
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
Abramson Cancer Center at Penn Medicine
Liquid-NET
Universiteit Antwerpen
NET-002
Sunnybrook Health Sciences Centre
Phase 2 Study of ONC201 in Neuroendocrine Tumors
Case Comprehensive Cancer Center
SurvivApp
Insel Gruppe AG, University Hospital Bern
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
EVACEL
Federation Francophone de Cancerologie Digestive
Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients
Yonsei University
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Olivia Newton-John Cancer Research Institute
Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective
Jonsson Comprehensive Cancer Center
DIB-NET
University Hospitals Coventry and Warwickshire NHS Trust
BANN
University Medical Center Groningen
WIN
University Medical Center Groningen
VIDEO-NET
University Medical Center Groningen
WIN
University Medical Center Groningen
DIVIT-pilot
University Medical Center Groningen
5-HIAA
University Medical Center Groningen
HET-NET
University Medical Center Groningen
The Indol Profile; Exploring the Metabolic Profile of Neuroendocrine Tumors
University Medical Center Groningen
DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor
University Medical Center Groningen